Article Information
- October 31, 2020.
Article Versions
- Version 1 (July 24, 2020 - 19:01).
- Version 2 (July 30, 2020 - 15:12).
- Version 3 (August 14, 2020 - 15:19).
- Version 4 (August 28, 2020 - 07:48).
- Version 5 (September 26, 2020 - 00:30).
- Version 6 (October 8, 2020 - 13:36).
- You are viewing Version 7, the most recent version of this article.
REVISION SUMMARY
(1) Robustness analysis now includes consideration of open-ended age groups (e.g., 65+ years), with detailed results shown in Appendix L. (2) U.S. scenario analysis now uses metaregression predictions by single year of age, with detailed results in Appendix N. (3) Comparison with seasonal influenza now incorporates confidence intervals, with details in Appendix O. (4) Discussion of relevance for developing countries, with detailed analysis of Manaus, Brazil in Appendix T.
Author Information
- Andrew T. Levin1,
- William P. Hanage2,
- Nana Owusu-Boaitey4,
- Kensington B. Cochran5,
- Seamus P. Walsh5 and
- Gideon Meyerowitz-Katz3,*
- 1professor of economics at Dartmouth College, research associate of the NBER, and international research fellow of the Centre for Economic Policy Research
- 2associate professor of epidemiology at the Harvard T.H. Chan School of Public Health
- 3epidemiologist at the University of Wollongong and research monitoring and surveillance coordinator at the Western Sydney Local Health District
- 4Ph.D. in immunology and is currently engaged in graduate work in medicine and bioethics at the Case Western Reserve University School of Medicine
- 5recent graduates of Dartmouth College
- ↵*Corresponding Author:
Gideon Meyerowitz-Katz, Research, Monitoring & Surveillance Coordinator, Western Sydney Local Health District, PO Box 792, Seven Hills, NSW 2147 Australia Phone: +61-2-9881-8878, Email: gideon.meyerowitzkatz{at}health.nsw.gov.au